Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Non Operating Income (2010 - 2026)

Vericel (VCEL) posted Non Operating Income of $1.8 million for Q2 2026, up 0.57% sequentially from $1.8 million in Q1 2026, and up 20.05% YoY from $1.5 million in Q2 2025.

Analysis

Vericel (VCEL) Non Operating Income (2010 - 2026) Analysis & Trends

Vericel has reported Non Operating Income for 17 years, with the latest figure at $1.8 million in Q2 2026.

  • Quarterly Non Operating Income rose 20.05% year-over-year to $1.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.8 million (up 12.92% YoY) and the FY2025 annual result came in at $6.3 million, up 5.71% from the prior year.
  • Non Operating Income grew to $1.8 million in Q2 2026 per VCEL's latest filing, from $1.8 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $1.8 million in Q2 2026 and troughed at $119000.0 in Q2 2022.
  • A 5-year average of $1.2 million and a median of $1.4 million in 2023 frame the typical range for Non Operating Income.
  • The sharpest annual moves came in 2022 and 2025: Non Operating Income soared 693.33% in 2022, then retreated 3.5% in 2025.
  • Over 5 years, Non Operating Income stood at $537000.0 in 2022, then jumped by 153.63% to $1.4 million in 2023, then increased by 8.37% to $1.5 million in 2024, then gained by 14.3% to $1.7 million in 2025, then grew by 5.04% to $1.8 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $1.8 million, $1.8 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -139.24 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -51.63 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 1.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.77 Mn
Mar 31, 2026 1.76 Mn
Dec 31, 2025 1.69 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 1.48 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 1.56 Mn
Jun 30, 2024 1.35 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.36 Mn
Sep 30, 2023 1.11 Mn
Jun 30, 2023 941,000.00
Mar 31, 2023 682,000.00
Dec 31, 2022 537,000.00
Sep 30, 2022 232,000.00
Jun 30, 2022 119,000.00
Mar 31, 2022 182,000.00
Dec 31, 2021 68,000.00
Sep 30, 2021 30,000.00